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Background: Digital ulcers (DU) are a burden in systemic sclerosis (SSc).
Microangiopathy is a cardinal feature of SSc that plays a critical role in the
development of DU. However, whether injury of medium or large vessels also
contributes to DU in SSc is unknown.
Methods:To measure concomitantly in SSc patients with and without active
DU i) the Augmentation Index of the reflected wave (Aix_75) by radial appla-
nation tonometry, an index of small and medium arterial function, II) the aortic
pulse wave velocity (PWV), a marker of large vessel injury (aortic stiffness).
Results: 63 consecutive SSc patients were included (49 females, aged
57±12 years, disease duration 9.7±7.1 years), including 10 (15.9%) with
active DU.
Patients with active DU versus those without had increased Aix_75 (35%
[28-38] versus 28% [20-34], p=0.041) whereas no difference existed in PWV
(7,0m/s [6.7-10.1] versus 7,6m/s [6.8-8.7], p=0.887), in systolic, diastolic, as
well as aortic pulse pressure (p=0.126, 0.592, and 0.161 respectively).
By multivariate analysis, DU remained independently associated with
Aix_75 (p=0.020). 
Using Aix_75 as a longitudinal variable, and when compared to patients in
the low tertile, patients having Aix_75 in the highest tertile had ten-fold more
DU (OR=10.23; 95% CI 1.12 to 93.34, p=0.039). 
Conclusion: The presence of DU is independently associated with Aix_75
whereas there is no relation with PWV. These data suggest that small and
medium arteries are involved in the occurrence of DU whether large vessel
stiffness does not contribute. Whether Aix_75 is predictive of further DU
remained to be studied.
0383
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Human tissue is three-dimensional, and requires convective transport of
nutrients and waste through capillary networks to meet metabolic demands
Angiogenesis is the formation of new blood vessels from the existing vascula-
ture. It is a multi-step process that include: degradation of the basement mem-
brane, proliferation and migration (sprouting) of endothelial cells (EC) into the
extracellular matrix, alignment of EC into cords, branching, lumen formation,
anastomosis, and formation of a new basement membrane. The literatture in 3D
in vitro models using endothelial cells is wide, using various types of EC (essen-
tially Human Umbilical Vein Endothelial Cells), but blood vessels are composed
of two interacting cells types: endothelial cells form the inner of the vessel wall,
and mural cells that wrap the first ones. Pericytes are the mural cells of
microvessels. They serve as scaffolding, and they communicate with endothelial
cells by direct physical contacts and paracrine signaling pathways. Presently,
there are no three-dimensional in vitro models of 3D Matrices which contain
human pericyte-coated capillaries. Therefore, we aim at including pericytes in a
3D vascular morphogenesis assay in order to create a 3D in vitro model more
close to physiologic conditions. We’ll show and discuss our first analyzes and
results, the goal of which is to provide new in vitro tools in order to better
understand vascular biology, for later studies of endothelial cells-pericytes inter-
actions, extracellular matrix-pericytes interactions, and eventually, further eluci-
date the role of pericytes in the microvasculature.
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Prostacyclin therapy has markedly improved the outcome of patients with pul-
monary hypertension (PH). Endothelial dysfunction is a key feature of PH, so the
aim of our study was to determine how treprostinil contributes to the angiogenic
functions of endothelial progenitors (ECFC). Treprostinil did not modify clono-
genic properties nor endothelial differentiation potential from cord blood stem
cells. Treprostinil treatment significantly increased the vessel-forming ability of
ECFC combined with mesenchymal stem cells (MSC) in Matrigel implanted in
nude mice. Silencing or blocking VEGF-A in MSC blocked the pro-angiogenic
effect of treprostinil in vitro and in vivo. Clinical relevance was confirmed by the
high level of VEGF-A detected in plasma from patients with pediatric pulmonary
hypertension who had been treated with treprostinil. Our results suggest that
VEGF-A level in patients could be a surrogate biomarker of treprostinil efficacy
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Fucoidans are natural sulfated polysaccharides used as glycosaminoglycans
(GAG) mimetics. Both GAGs and chemokines are important to regulate
angiogenesis and wound healing. Fucoidans interacts with pro-angiogenic che-
mokines, such as RANTES and SDF-1, leads to revascularization and
increases endothelial cell migration. However this pro-angiogenic activity
remains unclear and depends of the type of fucoidan. Innovative vascular ther-
apies based on GAG mimetic should be developed.
Upstream of developing a tissue engineering therapy, we propose to under-
stand the beneficial effect of fucoidans on angiogenesis by a structure-function
study. We hypothesize that the size and sulfation level could regulate the che-
mokines affinity and modulate its beneficial properties.
We purified and characterized 5 fractions of fucoidans according to their
sulfation rate. We tested their affinity to chemokines (Surface Plasmon Reso-
nance), the effect on endothelial cells (HUVEC) migration (Boyden chamber)
and their pro-angiogenic properties (Microvascular network formation). We
also analyzed the effect of fucoidans on endogen proteoglycans and GAG
expression (qRT-PCR, FACS).
The structural analysis of fucoidans resulted in fractions (5-27kDa) composed
of fucose, sulfate and uronic acid. The most sulfated fraction (5kDa with the ratio
sulfate/fucose at 1.87) presented high affinity to biotinylated-SDF-1 and
RANTES. Furthermore, this 5kDa fucoidan significantly increased HUVEC
migration and microvascular network formation compared to other fractions.
The 5 kDa fucoidan shows the highest pro-angiogenic effects on HUVEC.
Sulfate-rich 5kDa fucoidan confirmed our hypothesis than small and highly
sulfated fucoidan is attractive candidate to develop therapies based on revas-
cularization. We now focus to develop regenerative cell therapy of ischemic
heart based on the injection of progenitors cells coupled with pro-angiogenic
fucoidan and chemokines.
April 03rd, Friday 2015
